• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6
1
1
1

COUNTRY

1

CATEGORIES

  • 5
  • 4
  • 1
  • 1

PRICE

7
8
8
11

PUBLISHED

0
0
2
11

PRODUCT TYPE

7
4

Search "Jazz Pharmaceuticals, Inc.-Deals & Alliances Report" returned 11 results.

PRODUCT TITLE
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Cortex Pharmaceuticals, Inc. (CORX) - Financial and Strategic SWOT Analysis Review

Cortex Pharmaceuticals, Inc. (CORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

September 2013
FROM
Jazz Pharmaceuticals, Inc.-Detailed Product Pipeline Jazz Pharmaceuticals, Inc.-Detailed Product Pipeline - Product Thumbnail Image

Jazz Pharmaceuticals, Inc.-Detailed Product Pipeline

Jazz Pharmaceuticals, Inc.-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent...

March 2011
FROM
Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011 Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011

Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International, Inc. - Product Pipeline...

November 2011
FROM
Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Summary Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company....

March 2012
FROM

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM
Prescription Drugs - Global Strategic Business Report Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

July 2009
FROM
Valeant Pharmaceuticals International - Product Pipeline Review - Q4 2010 Valeant Pharmaceuticals International - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Valeant Pharmaceuticals International - Product Pipeline Review - Q4 2010

Valeant Pharmaceuticals International – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International - Product Pipeline Review -...

December 2010
FROM
Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2012 Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2012

Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International, Inc. - Product Pipeline...

May 2012
FROM
Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13 Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13 - Product Thumbnail Image

Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13

Abstract Standard & Poor's Ratings Services expects its ratings on the U.S. for-profit health care companies it rates to remain broadly stable in 2013, with a modest negative bias, primarily in the...

May 2013
Soft Drinks - Global Strategic Business Report Soft Drinks - Global Strategic Business Report - Product Thumbnail Image

Soft Drinks - Global Strategic Business Report

This report analyzes the worldwide markets for Soft Drinks in Millions of Liters and US$ Million The major product segments analyzed are Carbonates, and Non-Carbonates The sub product segments analyzed...

February 2006
FROM
Loading Indicator

Our Clients

Our clients' logos